Portfolio Holdings Detail for ISIN IE00BYXG2H39
| Stock Name / Fund | iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares IV Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300ZP07LMR36K1T02 |
| ETF Ticker | BTEC(USD) LSE |
| ETF Ticker | BTEK(GBP) LSE |
| ETF Ticker | 2B70(EUR) F |
| ETF Ticker | 2B70.DE(EUR) CXE |
| ETF Ticker | BTEC.LS(USD) CXE |
| ETF Ticker | BTEK.LS(GBP) CXE |
| ETF Ticker | BTEC.L(GBP) LSE |
| ETF Ticker | BTEK.L(GBP) LSE |
Holdings detail for CRVS
| Stock Name | Corvus Pharmaceuticals Inc |
| Ticker | CRVS(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US2210151005 |
| LEI | 549300I3AVJ8F75NCX65 |
Show aggregate CRVS holdings
News associated with CRVS
- Insider Selling: Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Director Sells 1,176,332 Shares of Stock
- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Free Report) Director Peter A. Thompson sold 1,176,332 shares of Corvus Pharmaceuticals stock in a transaction that occurred on Friday, June 27th. The stock was sold at an average price of $4.16, for a total transaction of $4,893,541.12. Following the completion of the sale, the director directly owned 7,165,006 […] - 2025-07-03 05:26:56
- Bank of America Corp DE Grows Position in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS)
- Bank of America Corp DE grew its holdings in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) by 23,611.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 96,981 shares of the company’s stock after acquiring an additional 96,572 shares during the period. […] - 2025-06-11 04:14:55
- Man Group plc Buys New Holdings in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS)
- Man Group plc bought a new stake in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) in the fourth quarter, Holdings Channel reports. The institutional investor bought 13,594 shares of the company’s stock, valued at approximately $73,000. A number of other large investors have also modified their holdings of CRVS. Virtus ETF Advisers LLC bought a […] - 2025-05-29 04:58:53
- StockNews.com Downgrades Corvus Pharmaceuticals (NASDAQ:CRVS) to Sell
- Corvus Pharmaceuticals (NASDAQ:CRVS – Get Free Report) was downgraded by research analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday. CRVS has been the subject of several other research reports. HC Wainwright reissued a “buy” rating and issued a $11.00 price target on shares of […] - 2025-05-22 03:12:43
- Graham Capital Management L.P. Takes Position in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS)
- Graham Capital Management L.P. bought a new stake in shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 18,305 shares of the company’s stock, valued at approximately $98,000. Other hedge funds have also modified […] - 2025-05-20 05:10:53
- Corvus Pharmaceuticals (NASDAQ:CRVS) Upgraded to “Hold” at StockNews.com
- Corvus Pharmaceuticals (NASDAQ:CRVS – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Monday. CRVS has been the topic of several other reports. Oppenheimer restated an “outperform” rating and set a $17.00 target price (up from $15.00) on shares of […] - 2025-05-14 02:14:45
- Raymond James Financial Inc. Purchases New Stake in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS)
- Raymond James Financial Inc. purchased a new position in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 108,989 shares of the company’s stock, valued at approximately $583,000. A number of other hedge funds and other institutional investors have also added to or reduced their stakes in CRVS. […] - 2025-05-08 04:24:54
- Geode Capital Management LLC Acquires 3,854 Shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS)
- Geode Capital Management LLC increased its holdings in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) by 0.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 566,863 shares of the company’s stock after purchasing an additional 3,854 shares during the period. Geode Capital Management LLC’s holdings […] - 2025-04-29 04:26:57
- Analysts Set Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Price Target at $12.38
- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Free Report) has been given a consensus rating of “Buy” by the five analysts that are presently covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1-year target […] - 2025-02-24 04:14:52
iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) CRVS holdings
| Date | Number of CRVS Shares Held | Base Market Value of CRVS Shares | Local Market Value of CRVS Shares | Change in CRVS Shares Held | Change in CRVS Base Value | Current Price per CRVS Share Held | Previous Price per CRVS Share Held |
|---|
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of CRVS by Blackrock for IE00BYXG2H39
Show aggregate share trades of CRVS| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-10-06 | BUY | 366 | 6.980 | 7.370 | 7.331 | USD 2,683 | 4.48 |
| 2025-10-03 | BUY | 847 | 7.190 | 7.390 | 7.370 | USD 6,242 | 4.47 |
| 2025-10-02 | BUY | 121 | 7.040 | 7.370 | 7.337 | USD 888 | 4.46 |
| 2025-09-30 | BUY | 242 | 7.370 | 7.410 | 7.406 | USD 1,792 | 4.42 |
| 2025-09-26 | BUY | 242 | 7.390 | 7.390 | 7.390 | USD 1,788 | 4.39 |
| 2025-09-25 | BUY | 242 | 6.610 | 6.630 | 6.628 | USD 1,604 | 4.38 |
| 2025-09-24 | SELL | -5,059 | 6.480 | 6.570 | 6.561 | USD -33,192 | 4.37  Loss of -11,097 on sale |
| 2025-09-18 | BUY | 138 | 6.120 | 6.140 | 6.138 | USD 847 | 4.36 |
| 2025-09-17 | BUY | 417 | 5.790 | 6.035 | 6.010 | USD 2,506 | 4.35 |
| 2025-09-11 | SELL | -137 | 6.060 | 6.080 | 6.078 | USD -833 | 4.31 Loss of -242 on sale |
| 2025-09-10 | BUY | 274 | 5.930 | 6.300 | 6.263 | USD 1,716 | 4.30 |
| 2025-09-05 | SELL | -137 | 6.160 | 6.170 | 6.169 | USD -845 | 4.27 Loss of -260 on sale |
| 2025-08-29 | SELL | -414 | 5.740 | 5.750 | 5.749 | USD -2,380 | 4.24 Loss of -626 on sale |
| 2025-08-27 | BUY | 274 | 5.500 | 5.610 | 5.599 | USD 1,534 | 4.22 |
| 2025-08-26 | SELL | -137 | 5.540 | 5.620 | 5.612 | USD -769 | 4.21 Loss of -191 on sale |
| 2025-08-25 | BUY | 137 | 5.450 | 5.620 | 5.603 | USD 768 | 4.21 |
| 2025-08-20 | SELL | -544 | 5.190 | 5.220 | 5.217 | USD -2,838 | 4.19 Loss of -557 on sale |
| 2025-08-18 | BUY | 272 | 5.320 | 5.810 | 5.761 | USD 1,567 | 4.18 |
| 2025-08-08 | SELL | -272 | 4.310 | 4.670 | 4.634 | USD -1,260 | 4.17 Loss of -127 on sale |
| 2025-08-05 | BUY | 135 | 4.290 | 4.350 | 4.344 | USD 586 | 4.17 |
| 2025-08-01 | SELL | -405 | 4.100 | 4.120 | 4.118 | USD -1,668 | 4.16  Profit of 19 on sale |
| 2025-07-30 | BUY | 540 | 4.380 | 4.665 | 4.636 | USD 2,504 | 4.16 |
| 2025-07-17 | SELL | -272 | 4.250 | 4.324 | 4.317 | USD -1,174 | 4.14 Loss of -48 on sale |
| 2025-07-11 | SELL | -1,096 | 4.140 | 4.230 | 4.221 | USD -4,626 | 4.14 Loss of -92 on sale |
| 2025-07-07 | BUY | 411 | 3.900 | 3.930 | 3.927 | USD 1,614 | 4.14 |
| 2025-07-02 | BUY | 7,590 | 3.980 | 4.090 | 4.079 | USD 30,960 | 4.14 |
| 2025-06-25 | BUY | 272 | 4.120 | 4.376 | 4.350 | USD 1,183 | 4.15 |
| 2025-06-20 | BUY | 9,206 | 3.960 | 4.000 | 3.996 | USD 36,787 | 4.15 |
| 2025-06-11 | BUY | 210 | 4.500 | 4.590 | 4.581 | USD 962 | 4.15 |
| 2025-06-10 | BUY | 210 | 4.250 | 4.335 | 4.327 | USD 909 | 4.15 |
| 2025-06-04 | SELL | -105 | 3.750 | 4.360 | 4.299 | USD -451 | 4.16 Loss of -15 on sale |
| 2025-04-23 | BUY | 105 | 3.520 | 3.660 | 3.646 | USD 383 | 4.36 |
| 2025-04-10 | SELL | -840 | 2.870 | 3.011 | 2.997 | USD -2,517 | 4.52 Profit of 1,281 on sale |
| 2025-04-08 | SELL | -105 | 2.820 | 3.140 | 3.108 | USD -326 | 4.57 Profit of 154 on sale |
| 2025-04-07 | SELL | -105 | 2.910 | 2.940 | 2.937 | USD -308 | 4.60 Profit of 175 on sale |
| 2025-04-04 | SELL | -525 | 2.850 | 2.970 | 2.958 | USD -1,553 | 4.63 Profit of 877 on sale |
| 2025-04-01 | BUY | 420 | 3.170 | 3.290 | 3.278 | USD 1,377 | 4.68 |
| 2025-03-31 | SELL | -315 | 3.180 | 3.430 | 3.405 | USD -1,073 | 4.70 Profit of 408 on sale |
| 2025-03-14 | SELL | -1,680 | 4.520 | 4.770 | 4.745 | USD -7,972 | 4.84 Profit of 156 on sale |
| 2025-03-07 | SELL | -212 | 4.620 | 4.800 | 4.782 | USD -1,014 | 4.88 Profit of 21 on sale |
| 2025-03-04 | SELL | -106 | 4.000 | 4.068 | 4.061 | USD -430 | 4.93 Profit of 92 on sale |
| 2025-02-25 | BUY | 212 | 3.940 | 4.100 | 4.084 | USD 866 | 5.07 |
| 2025-02-19 | SELL | -106 | 4.515 | 4.760 | 4.736 | USD -502 | 5.16 Profit of 45 on sale |
| 2025-02-13 | BUY | 315 | 4.920 | 5.190 | 5.163 | USD 1,626 | 5.21 |
| 2025-02-12 | BUY | 105 | 5.040 | 5.160 | 5.148 | USD 541 | 5.22 |
| 2025-02-11 | BUY | 420 | 4.960 | 5.250 | 5.221 | USD 2,193 | 5.23 |
| 2025-01-17 | BUY | 420 | 5.010 | 5.120 | 5.109 | USD 2,146 | 5.25 |
| 2025-01-16 | BUY | 420 | 4.730 | 4.915 | 4.896 | USD 2,057 | 5.33 |
| 2025-01-10 | SELL | -210 | 5.330 | 5.575 | 5.550 | USD -1,166 | 5.58 Profit of 5 on sale |
| 2025-01-08 | SELL | -420 | 5.650 | 5.890 | 5.866 | USD -2,464 | 5.43 Loss of -183 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of CRVS
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 158,879 | 17,713 | 270,618 | 58.7% |
| 2025-09-18 | 117,053 | 0 | 300,948 | 38.9% |
| 2025-09-17 | 99,397 | 0 | 172,816 | 57.5% |
| 2025-09-16 | 94,534 | 0 | 155,413 | 60.8% |
| 2025-09-15 | 114,637 | 100 | 294,529 | 38.9% |
| 2025-09-12 | 105,263 | 0 | 164,503 | 64.0% |
| 2025-09-11 | 111,316 | 0 | 196,722 | 56.6% |
| 2025-09-10 | 145,626 | 0 | 228,791 | 63.7% |
| 2025-09-09 | 123,037 | 500 | 202,047 | 60.9% |
| 2025-09-08 | 186,516 | 0 | 353,548 | 52.8% |
| 2025-09-05 | 235,672 | 0 | 433,026 | 54.4% |
| 2025-09-04 | 121,742 | 0 | 231,396 | 52.6% |
| 2025-09-03 | 152,368 | 40,922 | 223,645 | 68.1% |
| 2025-09-02 | 133,497 | 0 | 218,133 | 61.2% |
| 2025-08-29 | 103,861 | 0 | 240,337 | 43.2% |
| 2025-08-28 | 211,862 | 0 | 338,864 | 62.5% |
| 2025-08-27 | 91,041 | 0 | 370,153 | 24.6% |
| 2025-08-26 | 114,145 | 0 | 222,280 | 51.4% |
| 2025-08-25 | 91,884 | 0 | 161,063 | 57.0% |
| 2025-08-22 | 121,634 | 0 | 267,463 | 45.5% |
| 2025-08-21 | 68,680 | 179 | 113,329 | 60.6% |
| 2025-08-20 | 53,970 | 4,133 | 132,661 | 40.7% |
| 2025-08-19 | 138,393 | 693 | 194,850 | 71.0% |
| 2025-08-18 | 236,447 | 1,518 | 388,481 | 60.9% |
| 2025-08-15 | 131,697 | 0 | 296,559 | 44.4% |
| 2025-08-14 | 130,973 | 0 | 249,414 | 52.5% |
| 2025-08-13 | 92,800 | 415 | 266,902 | 34.8% |
| 2025-08-12 | 80,808 | 0 | 130,600 | 61.9% |
| 2025-08-11 | 73,204 | 70 | 134,734 | 54.3% |
| 2025-08-08 | 151,507 | 325 | 309,541 | 48.9% |
| 2025-08-07 | 162,905 | 0 | 243,641 | 66.9% |
| 2025-08-06 | 103,894 | 0 | 140,060 | 74.2% |
| 2025-08-05 | 119,826 | 0 | 133,061 | 90.1% |
| 2025-08-04 | 143,221 | 1,315 | 210,928 | 67.9% |
| 2025-08-01 | 230,488 | 0 | 317,697 | 72.5% |
| 2025-07-31 | 95,098 | 3,007 | 148,323 | 64.1% |
| 2025-07-30 | 86,815 | 600 | 177,502 | 48.9% |
| 2025-07-29 | 58,170 | 50 | 106,486 | 54.6% |
| 2025-07-28 | 74,534 | 0 | 115,917 | 64.3% |
| 2025-07-25 | 86,218 | 1,816 | 158,086 | 54.5% |
| 2025-07-24 | 170,524 | 551 | 341,458 | 49.9% |
| 2025-07-23 | 189,582 | 764 | 335,066 | 56.6% |
| 2025-07-22 | 148,232 | 0 | 170,694 | 86.8% |
| 2025-07-21 | 145,115 | 100 | 242,497 | 59.8% |
| 2025-07-18 | 92,721 | 0 | 152,032 | 61.0% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.
Copyright Market Footprint Ltd. Privacy Policy